In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML. (Q46547149)
Jump to navigation
Jump to search
scientific article published on 14 June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML. |
scientific article published on 14 June 2005 |
Statements
1 reference
In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML. (English)
1 reference
1 reference
Verity Saunders
1 reference
Susan Branford
1 reference
Andrew Grigg
1 reference
L Bik To
1 reference
Timothy Hughes
1 reference
14 June 2005
1 reference
1 reference
106
1 reference
7
1 reference
2520-2526
1 reference
Identifiers
1 reference